News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Foster Jonathan P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/14/2023 |
4
| Foster Jonathan P. (Director) has filed a Form 4 on Volcon, Inc.|
Txns:
| Granted 200,000 options
@ $0.69, valued at
$138k
|
|
| 03/16/2023 |
4/A
| Foster Jonathan P. (Director) has filed a Form 4 on Volcon, Inc.|
Txns:
| Granted 101,250 options
@ $1.55, valued at
$156.9k
|
|
| 08/12/2022 |
4
| Foster Jonathan P. (Director) has filed a Form 4 on Volcon, Inc.|
Txns:
| Granted 101,250 options
@ $1.55, valued at
$156.9k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2021 |
4
| Foster Jonathan P. (Director) has filed a Form 4 on Soliton, Inc.|
Txns:
| Disposed/sold 30,000 options to buy
@ $1.75, valued at
$52.5k
Disposed/sold 15,000 options to buy
@ $14.62, valued at
$219.3k
Disposed/sold 15,000 options to buy
@ $12.94, valued at
$194.1k
Disposed/sold 12,500 warrants
@ $1.75, valued at
$21.9k
|
|
| 10/05/2021 |
3
| Foster Jonathan P. (Director) has filed a Form 3 on Volcon, Inc. |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2019 |
4
| Foster Jonathan P. (Exec. Vice President and CFO) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 315,000 options to buy
@ $1.31, valued at
$412.7k
|
|
| 07/01/2019 |
4
| Foster Jonathan P. (Director) has filed a Form 4 on Soliton, Inc.|
Txns:
| Granted 15,000 options to buy
@ $14.62, valued at
$219.3k
|
|
| 02/22/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/08/2018 |
4
| Foster Jonathan P. (CFO) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 301,000 options to buy
@ $1.82, valued at
$547.8k
|
|
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2017 |
4
| Foster Jonathan P. (Exec. Vice President & CFO) has filed a Form 4 on Moleculin Biotech, Inc. |
| 08/23/2016 |
3
| Foster Jonathan P. (Exec. Vice President and CFO) has filed a Form 3 on Moleculin Biotech, Inc. |
| 08/18/2015 |
4
| Foster Jonathan P. (CFO) has filed a Form 4 on InfuSystem Holdings, Inc|
Txns:
| Bought 1,000 shares
@ $2.92, valued at
$2.9k
Bought 1,000 shares
@ $2.92, valued at
$2.9k
|
|
| 06/17/2015 |
4
| Foster Jonathan P. (CFO) has filed a Form 4 on InfuSystem Holdings, Inc|
Txns:
| Bought 312 shares
@ $3.12, valued at
$973.4 |
|
| 05/18/2015 |
4
| Foster Jonathan P. (CFO) has filed a Form 4 on InfuSystem Holdings, Inc|
Txns:
| Bought 4,270 shares
@ $3.07, valued at
$13.1k
|
|
| 03/13/2015 |
4
| Foster Jonathan P. (CFO) has filed a Form 4 on InfuSystem Holdings, Inc|
Txns:
| Granted 13,333 shares
@ $0 |
|
| 07/07/2014 |
4
| Foster Jonathan P. (CFO) has filed a Form 4 on InfuSystem Holdings, Inc|
Txns:
| Granted 100,000 options to buy
@ $2.674, valued at
$267.4k
|
|
| 03/14/2014 |
4
| Foster Jonathan P. (CFO) has filed a Form 4 on InfuSystem Holdings, Inc|
Txns:
| Bought 5,000 shares
@ $2.78, valued at
$13.9k
|
|
| 03/22/2012 |
3
| Foster Jonathan P. (CFO) has filed a Form 3 on InfuSystem Holdings, Inc |
|
|